文献速递艾滋病与性传播感染

HIV无症状状态对启动抗逆转录病毒治疗的依从性与结局的影响:瑞士HIV队列研究

The Role of Human Immunodeficiency Virus (HIV) Asymptomatic Status When Starting Antiretroviral Therapy on Adherence and Treatment Outcomes and Implications for Test and Treat: The Swiss HIV Cohort Study.
PubMed 文献 · Clin Infect Dis · 2021-01-01

瑞士HIV队列研究纳入2003–2018年7131例启动抗逆转录病毒治疗的HIV感染者,76%在无症状期启动治疗。

要点

  • 无症状期启动ART未增加不依从风险,不支持因担心准备不足而延迟治疗。

核心结论

  • 无症状HIV感染者启动ART未发现依从性问题或更差临床结局的证据。

研究设计与样本

  • 瑞士HIV队列研究(SHCS)纳入2003–2018年登记的7131例启动ART的HIV感染者。

主要发现

  • 7131例中76%在无症状期启动ART,1478例(22%)在中位1.9年(IQR 1.1–4.2)后发生病毒学失败。

关键数值与推荐

  • 无症状定义为启动ART后30天内CDC分期A期。
  • 不依从定义为任何自我报告的漏服剂量。
  • 病毒学失败定义为ART超过24周后连续两次病毒载量>50 copies/mL。

临床怎么用

  • 对无症状HIV感染者启动ART时,无需因担心依从性而延迟治疗。
  • 应关注无症状者中年轻、MSM、高教育、无保护性行为等特征人群的随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Since the advent of universal test-and-treat , more people living with human immunodeficiency virus (PLHIV) initiating antiretroviral therapy (ART) are asymptomatic with a preserved immune system. We explored the impact of asymptomatic status on adherence and clinical outcomes. METHODS: PLHIV registered in the Swiss HIV Cohort Study (SHCS) between 2003 and 2018 were included. We defined asymptomatic as Centers for Disease Control and Prevention stage A within 30 days of starting ART, non-adherence as any self-reported missed doses and viral failure as two consecutive viral load>50 copies/mL after >24 weeks on ART. Using logistic regression models, we measured variables associated with asymptomatic status and adherence and Cox proportional hazard models to assess association between symptom status and viral failure. RESULTS: Of 7131 PLHIV, 76% started ART when asymptomatic and 1478 (22%) experienced viral failure after a median of 1.9 years (interquartile range, 1.1-4.2). In multivariable models, asymptomatic PLHIV were more likely to be younger, men who have sex with men, better educated, have unprotected sex, have a HIV-positive partner, have a lower viral load, and have started ART more recently. Asymptomatic status was not associated with nonadherence (odds ratio, 1.03 [95% confidence interval {CI}, .93-1.15]). Asymptomatic PLHIV were at a decreased risk of viral failure (adjusted hazard ratio, 0.87 [95% CI, .76-1.00]) and less likely to develop resistance (14% vs 27%, P < .001) than symptomatic PLHIV. CONCLUSIONS: Despite concerns regarding lack of readiness, our study found no evidence of adherence issues or worse clinical outcomes in asymptomatic PLHIV starting ART.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Glass TR, Günthard HF, Calmy A, et al. The Role of Human Immunodeficiency Virus (HIV) Asymptomatic Status When Starting Antiretroviral Therapy on Adherence and Treatment Outcomes and Implications for Test and Treat: The Swiss HIV Cohort Study. Clin Infect Dis. 2021. PMID: 32157270. doi:10.1093/cid/ciaa239

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。